CW-069 is a selective inhibitor of ROCK2 kinase, used primarily in scientific research to study cellular mechanisms and biochemical processes. It is particularly valuable in drug development and disease treatment due to its specific properties that can modulate or inhibit the activity of certain proteins or enzymes. Additionally, it is employed in laboratory settings to test the efficacy and safety of new chemical entities before their application in medical or industrial contexts.